| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 19.33% | Piper Sandler | $305 → $280 | Maintains | Overweight |
| 11/10/2023 | 14.64% | Raymond James | $304 → $269 | Maintains | Outperform |
| 08/21/2023 | 20.18% | Citigroup | $260 → $282 | Maintains | Neutral |
| 08/07/2023 | 29.13% | Barclays | $284 → $303 | Maintains | Overweight |
| 08/04/2023 | 32.11% | Morgan Stanley | $295 → $310 | Maintains | Overweight |
| 08/04/2023 | 29.55% | Raymond James | $305 → $304 | Maintains | Outperform |
| 07/24/2023 | 29.98% | Piper Sandler | $290 → $305 | Maintains | Overweight |
| 07/24/2023 | 29.98% | Raymond James | → $305 | Upgrades | Market Perform → Outperform |
| 05/30/2023 | 25.72% | Morgan Stanley | → $295 | Assumes | → Overweight |
| 05/08/2023 | 10.8% | Citigroup | $250 → $260 | Maintains | Neutral |
| 05/08/2023 | 21.03% | Barclays | $282 → $284 | Maintains | Overweight |
| 05/05/2023 | 23.59% | Piper Sandler | $260 → $290 | Upgrades | Neutral → Overweight |
| 04/12/2023 | 29.55% | Keybanc | → $304 | Upgrades | Sector Weight → Overweight |
| 04/04/2023 | 17.2% | Evercore ISI Group | $280 → $275 | Maintains | Outperform |
| 02/03/2023 | 25.72% | Morgan Stanley | $290 → $295 | Maintains | Overweight |
| 02/03/2023 | 10.8% | Piper Sandler | $245 → $260 | Maintains | Neutral |
| 01/06/2023 | 23.59% | Morgan Stanley | $275 → $290 | Maintains | Overweight |
| 01/03/2023 | 23.59% | B of A Securities | $250 → $290 | Upgrades | Neutral → Buy |
| 12/12/2022 | 6.54% | Citigroup | $220 → $250 | Upgrades | Sell → Neutral |
| 11/23/2022 | 15.92% | Goldman Sachs | $319 → $272 | Maintains | Buy |
| 11/11/2022 | 4.41% | Piper Sandler | $255 → $245 | Maintains | Neutral |
| 10/11/2022 | 17.2% | Morgan Stanley | $272 → $275 | Maintains | Overweight |
| 08/16/2022 | 35.95% | Goldman Sachs | $278 → $319 | Maintains | Buy |
| 07/18/2022 | 19.33% | Stifel | $290 → $280 | Maintains | Buy |
| 07/15/2022 | 15.92% | Morgan Stanley | $282 → $272 | Maintains | Overweight |
| 07/11/2022 | 0.15% | Citigroup | $265 → $235 | Downgrades | Neutral → Sell |
| 06/24/2022 | 17.2% | Wells Fargo | → $275 | Upgrades | Equal-Weight → Overweight |
| 05/06/2022 | 20.18% | Morgan Stanley | $295 → $282 | Maintains | Overweight |
| 05/06/2022 | 8.67% | Piper Sandler | $265 → $255 | Maintains | Neutral |
| 04/11/2022 | 25.72% | Morgan Stanley | $293 → $295 | Maintains | Overweight |
| 04/01/2022 | 21.46% | Wells Fargo | $275 → $285 | Maintains | Equal-Weight |
| 03/28/2022 | 24.87% | Morgan Stanley | $310 → $293 | Maintains | Overweight |
| 02/04/2022 | 32.11% | Morgan Stanley | $300 → $310 | Maintains | Overweight |
| 02/04/2022 | 17.2% | SVB Leerink | $270 → $275 | Maintains | Market Perform |
| 01/07/2022 | 27.85% | Morgan Stanley | $285 → $300 | Maintains | Overweight |
| 12/08/2021 | 10.8% | Piper Sandler | $285 → $260 | Downgrades | Overweight → Neutral |
| 08/06/2021 | 12.93% | JP Morgan | → $265 | Downgrades | Overweight → Neutral |
| 08/06/2021 | 6.54% | SVB Leerink | $260 → $250 | Maintains | Market Perform |
| 05/25/2021 | 15.06% | Barclays | → $270 | Initiates Coverage On | → Equal-Weight |
| 05/07/2021 | 10.8% | SVB Leerink | $270 → $260 | Maintains | Market Perform |
| 02/05/2021 | 19.33% | Citigroup | $273 → $280 | Maintains | Neutral |
| 01/29/2021 | 20.18% | Raymond James | $270 → $282 | Maintains | Outperform |
| 12/15/2020 | 26.57% | Morgan Stanley | → $297 | Upgrades | Equal-Weight → Overweight |
| 12/15/2020 | 12.93% | Wells Fargo | → $265 | Downgrades | Overweight → Equal-Weight |
| 11/06/2020 | 11.66% | Morgan Stanley | $270 → $262 | Maintains | Equal-Weight |
| 10/12/2020 | 15.06% | Raymond James | $285 → $270 | Maintains | Outperform |
| 08/27/2020 | 15.06% | Morgan Stanley | $285 → $270 | Maintains | Equal-Weight |
| 08/10/2020 | 19.33% | UBS | $265 → $280 | Maintains | Neutral |
| 08/10/2020 | 21.46% | Morgan Stanley | $248 → $285 | Maintains | Equal-Weight |
| 08/07/2020 | 21.46% | Raymond James | $265 → $285 | Maintains | Outperform |
| 07/15/2020 | 18.05% | SVB Leerink | $262 → $277 | Maintains | Market Perform |
| 07/09/2020 | 27.85% | Barclays | → $300 | Upgrades | Equal-Weight → Overweight |
| 06/25/2020 | 5.69% | Morgan Stanley | $255 → $248 | Maintains | Equal-Weight |
| 06/25/2020 | 12.93% | Raymond James | $290 → $265 | Maintains | Outperform |
| 06/01/2020 | 18.47% | Goldman Sachs | → $278 | Initiates Coverage On | → Buy |
| 05/14/2020 | 26.15% | Piper Sandler | $286 → $296 | Maintains | Overweight |
| 05/08/2020 | 11.66% | SVB Leerink | $245 → $262 | Reiterates | → Market Perform |
| 05/08/2020 | 19.33% | Stifel | $265 → $280 | Maintains | Buy |
| 05/08/2020 | 12.93% | UBS | $260 → $265 | Maintains | Neutral |
| 05/08/2020 | 18.47% | CFRA | $285 → $278 | Maintains | Hold |
| 05/08/2020 | 23.59% | Raymond James | $283 → $290 | Maintains | Outperform |
| 05/08/2020 | 10.8% | Citigroup | $234 → $260 | Maintains | Neutral |
| 04/08/2020 | 4.41% | SVB Leerink | $269 → $245 | Maintains | Market Perform |
| 04/08/2020 | 15.06% | Wells Fargo | $279 → $270 | Maintains | Overweight |
| 04/01/2020 | 12.93% | Stifel | $280 → $265 | Maintains | Buy |
| 03/27/2020 | -0.28% | Citigroup | $260 → $234 | Maintains | Neutral |
| 03/27/2020 | 8.67% | Morgan Stanley | $271 → $255 | Maintains | Equal-Weight |
| 03/05/2020 | 10.8% | Citigroup | → $260 | Initiates Coverage On | → Neutral |
| 02/07/2020 | 15.49% | Morgan Stanley | $287 → $271 | Maintains | Equal-Weight |
| 02/07/2020 | 18.9% | Wells Fargo | $285 → $279 | Maintains | Overweight |
| 02/07/2020 | 20.61% | Raymond James | $288 → $283 | Downgrades | Strong Buy → Outperform |
| 02/07/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 02/07/2020 | 17.2% | Cowen & Co. | $306 → $275 | Downgrades | Outperform → Market Perform |
| 02/06/2020 | 21.46% | CFRA | $304 → $285 | Downgrades | Buy → Hold |
| 01/22/2020 | 27% | Keybanc | $284 → $298 | Maintains | Overweight |
| 01/08/2020 | 17.2% | Barclays | → $275 | Downgrades | Overweight → Equal-Weight |
| 12/20/2019 | 27.85% | JP Morgan | $285 → $300 | Maintains | Overweight |
| 12/17/2019 | 22.31% | Morgan Stanley | $261 → $287 | Maintains | Equal-Weight |
| 12/16/2019 | 25.72% | Stifel | $275 → $295 | Maintains | Buy |
| 11/13/2019 | 9.1% | Keybanc | $262 → $256 | Maintains | Overweight |
| 11/06/2019 | 21.46% | Wells Fargo | $290 → $285 | Maintains | Outperform |
| 09/06/2019 | 23.59% | Wells Fargo | $270 → $290 | Maintains | Outperform |
| 07/16/2019 | 11.23% | Morgan Stanley | $250 → $261 | Maintains | Equal-Weight |
| 06/28/2019 | 22.74% | Raymond James | $265 → $288 | Maintains | Strong Buy |
| 05/13/2019 | 13.36% | Barclays | → $266 | Upgrades | Equal-Weight → Overweight |
| 05/10/2019 | 15.06% | BMO Capital | $272 → $270 | Maintains | Market Perform |
| 05/10/2019 | 6.54% | Morgan Stanley | $255 → $250 | Maintains | Equal-Weight |
| 05/10/2019 | 6.54% | UBS | $265 → $250 | Maintains | Neutral |
| 05/10/2019 | 11.66% | Keybanc | $273 → $262 | Maintains | Overweight |
| 04/15/2019 | 13.36% | Barclays | $260 → $266 | Maintains | Equal-Weight |
| 03/19/2019 | 19.33% | Raymond James | $290 → $280 | Maintains | Strong Buy |
| 01/02/2019 | 2.28% | Morgan Stanley | $265 → $240 | Maintains | Equal-Weight |
| 01/02/2019 | 9.1% | Citigroup | $279 → $256 | Maintains | Buy |
| 12/07/2018 | 19.33% | Deutsche Bank | → $280 | Initiates Coverage On | → Buy |
| 11/28/2018 | 10.8% | UBS | → $260 | Initiates Coverage On | → Neutral |
| 11/13/2018 | 18.9% | Citigroup | $289 → $279 | Maintains | Buy |
What is the target price for Becton Dickinson (BDX)?
The latest price target for Becton Dickinson (NYSE: BDX) was reported by Piper Sandler on November 10, 2023. The analyst firm set a price target for $280.00 expecting BDX to rise to within 12 months (a possible 19.33% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Becton Dickinson (BDX)?
The latest analyst rating for Becton Dickinson (NYSE: BDX) was provided by Piper Sandler, and Becton Dickinson maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Becton Dickinson (BDX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Becton Dickinson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Becton Dickinson was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
Is the Analyst Rating Becton Dickinson (BDX) correct?
While ratings are subjective and will change, the latest Becton Dickinson (BDX) rating was a maintained with a price target of $305.00 to $280.00. The current price Becton Dickinson (BDX) is trading at is $234.65, which is out of the analyst's predicted range.